These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11320045)

  • 1. Randomised controlled trial of prophylactic etamsylate: follow up at 2 years of age.
    Elbourne D; Ayers S; Dellagrammaticas H; Johnson A; Leloup M; Lenoir-Piat S;
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F183-7. PubMed ID: 11320045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial.
    Schulte J; Osborne J; Benson JW; Cooke R; Drayton M; Murphy J; Rennie J; Speidel B
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F31-5. PubMed ID: 15613570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethamsylate for the prevention of morbidity and mortality in preterm or very low birth weight infants.
    Hunt R; Hey E
    Cochrane Database Syst Rev; 2010 Jan; (1):CD004343. PubMed ID: 20091562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EC randomised controlled trial of prophylactic ethamsylate for very preterm neonates: early mortality and morbidity. The EC Ethamsylate Trial Group.
    Arch Dis Child Fetal Neonatal Ed; 1994 May; 70(3):F201-5. PubMed ID: 8198414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etamsylate for prevention of periventricular haemorrhage.
    Hunt RW
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F3-5. PubMed ID: 15613569
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomised trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: outcome at 2 years. Northern Neonatal Nursing Initiative Trial Group.
    Lancet; 1996 Jul; 348(9022):229-32. PubMed ID: 8684200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ethamsylate in preventing periventricular-intraventricular hemorrhage in premature infants below 34 weeks of gestation.
    Sanghvi KP; Merchant RH; Karnik A; Kulkarni A
    Indian Pediatr; 1999 Jul; 36(7):653-8. PubMed ID: 10740301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of neurodevelopmental impairment for outborn extremely preterm infants in an Australian regional network.
    Mahoney K; Bajuk B; Oei J; Lui K; Abdel-Latif ME;
    J Matern Fetal Neonatal Med; 2017 Jan; 30(1):96-102. PubMed ID: 26957041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study.
    Larroque B; Ancel PY; Marret S; Marchand L; André M; Arnaud C; Pierrat V; Rozé JC; Messer J; Thiriez G; Burguet A; Picaud JC; Bréart G; Kaminski M;
    Lancet; 2008 Mar; 371(9615):813-20. PubMed ID: 18328928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular haemorrhage in preterm infants--can we improve outcome by addressing coagulation?
    Kuperman AA; Brenner B; Kenet G
    J Matern Fetal Neonatal Med; 2015 Nov; 28 Suppl 1():2265-7. PubMed ID: 23968273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethamsylate in the prevention of periventricular-intraventricular hemorrhage in premature infants.
    Chen JY
    J Formos Med Assoc; 1993 Oct; 92(10):889-93. PubMed ID: 7908570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extreme prematurity: comparison of outcome at 5 years depending on gestational age below or above 26 weeks].
    Autret F; Kieffer F; Tasseau A; Rigourd V; Valleur D; Voyer M; Magny JF
    Arch Pediatr; 2009 Jul; 16(7):976-83. PubMed ID: 19403280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study.
    Pierrat V; Marchand-Martin L; Arnaud C; Kaminski M; Resche-Rigon M; Lebeaux C; Bodeau-Livinec F; Morgan AS; Goffinet F; Marret S; Ancel PY;
    BMJ; 2017 Aug; 358():j3448. PubMed ID: 28814566
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental Outcomes of Infants Born at <29 Weeks of Gestation Admitted to Canadian Neonatal Intensive Care Units Based on Location of Birth.
    Amer R; Moddemann D; Seshia M; Alvaro R; Synnes A; Lee KS; Lee SK; Shah PS;
    J Pediatr; 2018 May; 196():31-37.e1. PubMed ID: 29305231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants.
    Ibrahim M; Sinn J; McGuire W
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005253. PubMed ID: 16625632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morbidity and mortality of extremely low gestational age infants in Schleswig-Holstein. Follow-up at three to six years corrected age of infants < 27 + 0 weeks gestation in Schleswig-Holstein, Germany].
    Rapp M; Thyen U; Müller-Steinhardt K; Kohl M
    Z Geburtshilfe Neonatol; 2005 Aug; 209(4):135-43. PubMed ID: 16138271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional abilities at age 4 years of children born before 29 weeks of gestation.
    Johnson A; Townshend P; Yudkin P; Bull D; Wilkinson AR
    BMJ; 1993 Jun; 306(6894):1715-8. PubMed ID: 7688251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997.
    Mikkola K; Ritari N; Tommiska V; Salokorpi T; Lehtonen L; Tammela O; Pääkkönen L; Olsen P; Korkman M; Fellman V
    Pediatrics; 2005 Dec; 116(6):1391-400. PubMed ID: 16322163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.
    Serenius F; Källén K; Blennow M; Ewald U; Fellman V; Holmström G; Lindberg E; Lundqvist P; Maršál K; Norman M; Olhager E; Stigson L; Stjernqvist K; Vollmer B; Strömberg B;
    JAMA; 2013 May; 309(17):1810-20. PubMed ID: 23632725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.